Don't Rely on Pregnancy Letter Categories to Make Treatment Recommendations

August 2015

Pregnancy categories (A, B, C, D, X) will start to DISAPPEAR from Rx drug labels...due to new rules on reporting pregnancy and lactation risks.

It's been a long time coming...over 20 years since FDA's labeling change initiative began. Now it's finally starting to hit drug labels.

More relevant info to help with therapy decisions will replace the A, B, C, D, and X categories...because these "letters" oversimplify and don't consistently explain the degree of fetal risk.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote